RPG Life Sciences Limited
RPG Life Sciences Ltd is engaged in the manufacturing and marketing of Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs) in the domestic and international market.The company is a part of RPG group which is a diversified conglomerate with interests in areas of infrastructure, tyres, information technology, pharmaceuticals, energy and plantations.The group is headed by Harsh Goenka.
What RPG files
- Others64
- Updates30
- Important25
- Investor Meet25
- Board Meeting15
- PPTs10
RPG Life Sciences' subsidiary RPG Active Pharma acquired Raghava Life Sciences' API business for up to ₹135 crore. This expands RPGAP's integrated API capabilities, adding 22 commercialized APIs, 7 in development, and ~300 KL manufacturing capacity from an EU-GMP facility.
RPG Life Sciences' subsidiary approved acquiring Raghava Life Sciences' API & intermediates business as a slump sale for up to 135 Cr. This expands RPG's API footprint, adding manufacturing, R&D, and 29 molecules. The acquired business generated 19 Cr revenue in FY26.
RPG Life Sciences' subsidiary RPG Active Pharma is acquiring Raghava Life Sciences' API and intermediates business for up to ₹135 Cr cash. The acquired unit generated ~₹19 Cr revenue in FY26, including manufacturing, R&D, and 29 API molecules, significantly expanding RPG Life's API portfolio.
RPG Life Sciences has cancelled its scheduled Investors/Analysts meet, previously announced. Investors should note this change in upcoming communication plans.
RPG Life Sciences transferred its API business to a new subsidiary, RPG Active Pharma, which secured an initial INR 243 Cr from InvAscent. RPGAP will acquire Actis Generics, aiming to expand manufacturing and product portfolio with total investments up to INR 700 Cr.